- Home
- HMST vs VYGR Comparison
HMST vs VYGR Comparison
Compare HMST & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- VYGR
- Stock Information
- Founded
- HMST 1921
- VYGR 2013
- Country
- HMST United States
- VYGR United States
- Employees
- HMST N/A
- VYGR N/A
- Industry
- HMST Major Banks
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- HMST Finance
- VYGR Health Care
- Exchange
- HMST Nasdaq
- VYGR Nasdaq
- Market Cap
- HMST 287.6M
- VYGR 342.5M
- IPO Year
- HMST 2012
- VYGR 2015
- Fundamental
- Price
- HMST $10.86
- VYGR $5.78
- Analyst Decision
- HMST Buy
- VYGR Strong Buy
- Analyst Count
- HMST 2
- VYGR 9
- Target Price
- HMST $14.75
- VYGR $16.44
- AVG Volume (30 Days)
- HMST 153.6K
- VYGR 472.1K
- Earning Date
- HMST 01-27-2025
- VYGR 11-12-2024
- Dividend Yield
- HMST N/A
- VYGR N/A
- EPS Growth
- HMST N/A
- VYGR N/A
- EPS
- HMST N/A
- VYGR 0.47
- Revenue
- HMST $169,710,000.00
- VYGR $163,784,000.00
- Revenue This Year
- HMST N/A
- VYGR N/A
- Revenue Next Year
- HMST $12.08
- VYGR N/A
- P/E Ratio
- HMST N/A
- VYGR $12.39
- Revenue Growth
- HMST N/A
- VYGR 3.40
- 52 Week Low
- HMST $8.09
- VYGR $5.19
- 52 Week High
- HMST $16.10
- VYGR $11.72
- Technical
- Relative Strength Index (RSI)
- HMST 39.25
- VYGR 42.16
- Support Level
- HMST $10.60
- VYGR $5.53
- Resistance Level
- HMST $11.95
- VYGR $6.55
- Average True Range (ATR)
- HMST 0.47
- VYGR 0.32
- MACD
- HMST -0.05
- VYGR -0.05
- Stochastic Oscillator
- HMST 19.51
- VYGR 21.55
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.